Page 14 - ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2021 Financial Results  |  0  Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care and dermatological conditions today announced financial results for fiscal year 2021 and the fourth quarter ended March 31, 2021. “For the past 18 months we have been restructuring the Company to cut losses while positioning it for growth,” said Amy Trombly, CEO. “Last year we consolidated all manufacturing at our factory in Mexico (June), and ended our contract with Invekra that required us to sell product with low margin (October). This year, we entered into a partnership agreement with EMC Pharma, LLC for the sale

United statesNew zealandHong kongTestsieger finanztestGabriel scienceTe arai biofarma ltdSonoma pharmaceuticals incCpharmaceuticals aktieExchange commissionSonoma pharmaceuticalsVetsynova coNasocyn nasal careOracyn oralMiddle eastQuarter ended marchLatin america